• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    INSYS Therapeutics, Inc. (INSY)

    -NasdaqGM
    34.23 Up 0.65(1.94%) Sep 4, 4:00PM EDT
    |After Hours : 34.23 Down 0.00 (0.01%) Sep 4, 4:44PM EDT
    Add to Portfolio
    Prev Close:33.58
    Open:32.86
    Bid:31.30 x 3000
    Ask:38.64 x 900
    1y Target Est:36.75
    Beta:-0.160763
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:32.70 - 34.96
    52wk Range:15.45 - 46.17
    Volume:571,766
    Avg Vol (3m):893,031
    Market Cap:2.44B
    P/E (ttm):70.00
    EPS (ttm):0.49
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INSY

    Comparison

    Symbol% ChgMkt Cap
    INSYUp 1.94%2.44B
    AGNDown 1.24%115.63B
    ABTDown 2.42%64.19B

    Key Statistics

    Forward P/E (1 yr):28.29
    P/S (ttm):8.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.93
    Quarterly EPS Est (Sep-15) :0.23
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.29

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a proprietary sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback